Torno Capital »

Summit Therapeutics shares owned by Torno Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Torno Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 49k 21.90

More positions owned by Torno Capital

Scorpio Tankers SHS Call Option (STNG)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Nabors Industries SHS Put Option (NBR)
BlackRock Call Option
Meta Platforms Cl A Call Option (META)
Abbvie Call Option (ABBV)
Alphabet Inc Cap Stk CL C (GOOG)
Extra Space Storage Call Option (EXR)
KB Home Put Option (KBH)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
AutoZone Put Option (AZO)
Zoetis Cl A Call Option (ZTS)
United Therapeutics Corporation Put Option (UTHR)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Vaxcyte Put Option (PCVX)

View all positions for Torno Capital

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Millennium Management
Twin Tree Management
Darwin Global Management

View all funds holding Summit Therapeutics